# Ruiji Weisi Biotechnology (Shanghai)

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ruiji-weisi-biotechnology-shanghai

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Total disclosed funding: $2.2M
- Latest round: Angel (Aug 26, 2022)
- Investors on record: 2

## About

Based in Shanghai, China, and founded in 2021, Ruiji Weisi Biotechnology (Shanghai) operates as a biopharmaceutical company. In August 2022, it completed angel funding from Shenzhen HTI, Chengdu Shengao Investment Small and Medium Stake Equity Investment Management, and individual investors.

The company is engaged in medical research and experimental development, cell technology research and development and application, and sales of Class I and Class II medical devices. It has started the safety evaluation and IND filing for its first stem cell product.

## Funding rounds

- Angel, Aug 26, 2022, $2.2M — Shenzhen HTI, Chengdu Shengao Investment Small and Medium Stake Equity Investment Management

## Investors

- Shenzhen HTI (https://capitalatlas.ai/funds/shenzhen-hti) — Angel
- Chengdu Shengao Investment Small and Medium Stake Equity Investment Management — Angel